Bath & Body Works (NYSE:BBWI) Issues Q4 2025 Earnings Guidance

Bath & Body Works (NYSE:BBWI) updated its fourth quarter 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 1.700- for the period, compared to the consensus estimate of 2.160. The company issued revenue guidance of -. Bath & Body Works also updated its FY 2025 guidance to 2.870- EPS.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $26.00 target price on shares of Bath & Body Works in a research note on Monday, October 6th. Weiss Ratings reissued a “hold (c-)” rating on shares of Bath & Body Works in a report on Wednesday, October 8th. Wall Street Zen cut Bath & Body Works from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. Citigroup reiterated a “buy” rating on shares of Bath & Body Works in a research note on Friday. Finally, Robert W. Baird restated a “neutral” rating and issued a $19.00 price objective (down previously from $33.00) on shares of Bath & Body Works in a research note on Thursday. Seven analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat, Bath & Body Works currently has a consensus rating of “Hold” and a consensus target price of $29.90.

Bath & Body Works Stock Performance

Shares of BBWI opened at $15.83 on Friday. The stock has a fifty day moving average price of $24.83 and a two-hundred day moving average price of $28.25. The company has a market cap of $3.26 billion, a price-to-earnings ratio of 4.70, a PEG ratio of 0.86 and a beta of 1.53. Bath & Body Works has a 52-week low of $15.43 and a 52-week high of $41.87.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Thursday, November 20th. The company reported $0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). The business had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.64 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business’s quarterly revenue was down 1.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.49 earnings per share. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. As a group, research analysts predict that Bath & Body Works will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Friday, November 21st will be issued a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, November 21st. This represents a $0.80 annualized dividend and a yield of 5.1%. Bath & Body Works’s dividend payout ratio is currently 23.74%.

Institutional Investors Weigh In On Bath & Body Works

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Geneos Wealth Management Inc. lifted its stake in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after acquiring an additional 801 shares during the period. Danske Bank A S bought a new stake in Bath & Body Works during the 3rd quarter worth about $39,000. Advisory Services Network LLC acquired a new position in Bath & Body Works during the 3rd quarter valued at about $48,000. EverSource Wealth Advisors LLC boosted its stake in shares of Bath & Body Works by 155.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 4,456 shares of the company’s stock valued at $134,000 after purchasing an additional 2,714 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of Bath & Body Works during the 3rd quarter worth approximately $173,000. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.